KDM3A Ablation Activates Endogenous Retrovirus Expression to Stimulate Antitumor Immunity in Gastric Cancer
Jiabin Zheng,
No information about this author
Huolun Feng,
No information about this author
Jiatong Lin
No information about this author
et al.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
11(40)
Published: July 19, 2024
Abstract
The
success
of
immunotherapy
for
cancer
treatment
is
limited
by
the
presence
an
immunosuppressive
tumor
microenvironment
(TME);
Therefore,
identifying
novel
targets
to
that
can
reverse
this
TME
and
enhance
efficacy
essential.
In
study,
enrichment
analysis
based
on
publicly
available
single‐cell
bulk
RNA
sequencing
data
from
gastric
patients
are
conducted,
found
tumor‐intrinsic
interferon
(IFN)
plays
a
central
role
in
regulation.
results
shows
KDM3A
over‐expression
suppresses
IFN
response
inhibits
KDM3A,
either
genomically
or
pharmacologically,
which
effectively
promotes
responses
activating
endogenous
retroviruses
(ERVs).
ablation
reconfigures
dsRNA‐MAVS‐IFN
axis
modulating
H3K4me2,
enhancing
infiltration
function
CD8
T
cells,
simultaneously
reducing
regulatory
resulting
reshaped
vivo.
addition,
combining
anti‐PD1
therapy
with
inhibition
inhibited
growth.
conclusions,
study
highlights
as
potential
target
remodeling
enhancement
antitumor
immunity
through
regulation
ERV‐MAVS‐IFN
axis.
Language: Английский
Dual roles of human endogenous retroviruses in cancer progression and antitumor immune response
S.Y. Cindy Yang,
No information about this author
Surong Dong,
No information about this author
Benshuai You
No information about this author
et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer,
Journal Year:
2024,
Volume and Issue:
1879(6), P. 189201 - 189201
Published: Oct. 18, 2024
Language: Английский
Application of large-scale and multicohort plasma proteomics data to discover novel causal proteins in gastric cancer
Discover Oncology,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Oct. 18, 2024
Gastric
cancer
(GC)
is
one
of
the
most
common
malignant
tumors
threatening
human
beings
and
has
a
poor
prognosis.
Therefore,
exploring
unveiled
biomarkers
or
therapeutic
targets
for
diagnosis
treatment
GC
crucial.
A
total
5772
protein
quantitative
trait
loci
(pQTL)
were
aggregated
from
four
latest
large-scale
proteomics
cohorts.
Two-sample
Mendelian
randomization
(two-sample
MR)
was
utilized
to
identify
causal
effect
blood
plasma
proteins
on
GC.
Heterogeneity,
pleiotropy,
directionality
analyses
employed
evaluate
identified
via
two-sample
MR.
The
robustness
results
further
validated
colocalization.
drug
evaluated
reveal
compounds
that
can
interfere
with
these
proteins.
Ten
potential
causations
in
relation
identified:
LY6D,
SLURP1,
MLN,
PSCA,
THSD1,
CFTR,
PPM1B,
KDM3A,
TSC1,
HCG22.
Among
proteins,
THSD1
considered
as
reliable
due
their
significant
H4
posterior
probabilities
colocalization
analysis
absence
pleiotropy.
Compound
35,
nitrosamide,
0175029-0000
drugs
small
molecules
targeting
respectively.
This
study
several
provided
data
support
new
insights
into
early
diagnosis,
intervention,
Language: Английский
Exploring Xiaojianzhong decoction's potential in gastric cancer treatment: Integrative insights and experimental validation
Chun‐Han Cheng,
No information about this author
Wen‐Rui Hao,
No information about this author
Tzu-Hurng Cheng
No information about this author
et al.
World Journal of Gastrointestinal Oncology,
Journal Year:
2024,
Volume and Issue:
16(12), P. 4553 - 4558
Published: Nov. 8, 2024
Gastric
cancer
(GC)
remains
a
formidable
global
health
concern
with
significant
morbidity
and
mortality
rates,
despite
the
fact
that
numerous
advances
have
been
made
to
improve
conventional
therapies.
Xiaojianzhong
decoction
(XJZ),
traditional
Chinese
medicine,
has
garnered
academic
attention
as
multicomponent,
multitarget
approach
managing
GC.
The
present
editorial
explores
potential
of
XJZ
in
treatment
GC
through
comprehensive
analysis
network
pharmacology
experimental
validation.
Network
was
used
identify
key
molecular
targets
XJZ,
including
interleukin
6,
prostaglandin-endoperoxide
synthase
2,
matrix
metalloproteinase
9,
Language: Английский